TABLE 3.
STI Knowledge, HIV Stigma, and Prevention Self-Efficacy Outcomes for the 3 Intervention Conditions
| Health Education | Risk Reduction | Enhanced Partner Notification | Condition | Condition × Gender | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Wald χ2 | P | Wald χ2 | P | |
| STI knowledge | ||||||||||
| Baseline | ||||||||||
| All participants | 2.8 | 1.0 | 2.8 | 0.9 | 2.6 | 0.9 | 4.59 | 0.10 | 4.37 | 0.11 |
| Men | 2.8 | 1.0 | 2.9 | 0.9 | 2.6 | 0.9 | ||||
| Women | 2.7 | 1.0 | 2.8 | 1.0 | 2.7 | 0.9 | ||||
| 3 mo | ||||||||||
| All participants | 3.0 | 0.9 | 3.1 | 0.9 | 3.1 | 0.9 | ||||
| Men | 3.1 | 0.9 | 3.0 | 0.9 | 3.0 | 0.8 | ||||
| Women | 2.9 | 0.8 | 3.2 | 0.8 | 3.1 | 0.9 | ||||
| 6 mo | ||||||||||
| All participants | 3.1 | 0.9 | 3.1 | 0.8 | 3.2 | 0.8 | ||||
| Men | 3.2 | 0.8 | 3.1 | 0.9 | 3.1 | 0.7 | ||||
| Women | 3.1 | 0.9 | 3.2 | 0.8 | 3.3 | 0.8 | ||||
| 9 mo | ||||||||||
| All participants | 3.1 | 0.8 | 3.2 | 0.8 | 3.2 | 0.8 | ||||
| Men | 3.1 | 0.9 | 3.2 | 0.8 | 3.1 | 0.9 | ||||
| Women | 3.1 | 0.8 | 3.1 | 0.8 | 3.2 | 0.8 | ||||
| HIV stigma | ||||||||||
| Baseline | ||||||||||
| All participants | 2.3 | 0.5 | 2.3 | 0.4 | 2.3 | 0.4 | 4.48 | 0.10 | 0.77 | 0.68 |
| Men | 2.3 | 0.4 | 2.3 | 0.5 | 2.3 | 0.04 | ||||
| Women | 2.3 | 0.04 | 2.3 | 0.4 | 2.3 | 0.4 | ||||
| 3 mo | ||||||||||
| All participants | 1.2 | 0.4 | 1.1 | 0.3 | 1.2 | 0.4 | ||||
| Men | 1.2 | 0.4 | 1.1 | 0.4 | 1.2 | 0.4 | ||||
| Women | 1.2 | 0.4 | 1.1 | 0.3 | 1.2 | 0.3 | ||||
| 6 mo | ||||||||||
| All participants | 1.2 | 0.3 | 1.1 | 0.3 | 1.1 | 0.3 | ||||
| Men | 1.1 | 0.3 | 1.1 | 0.4 | 1.1 | 0.3 | ||||
| Women | 1.2 | 0.4 | 1.1 | 0.3 | 1.1 | 0.2 | ||||
| 9 mo | ||||||||||
| All participants | 1.1 | 0.3 | 1.1 | 0.3 | 1.1 | 0.3 | ||||
| Men | 1.2 | 0.3 | 1.1 | 0.4 | 1.1 | 0.4 | ||||
| Women | 1.1 | 0.3 | 1.1 | 0.2 | 1.1 | 0.2 | ||||
| Prevention self-efficacy | ||||||||||
| Baseline | ||||||||||
| All participants | 8.1 | 1.6 | 8.0 | 1.7 | 7.9 | 1.7 | 5.17 | 0.07 | 0.12 | 0.94 |
| Men | 8.2 | 1.5 | 8.0 | 1.6 | 7.9 | 1.8 | ||||
| Women | 7.9 | 1.7 | 8.1 | 1.9 | 8.0 | 1.7 | ||||
| 3 mo | ||||||||||
| All participants | 8.1 | 1.7 | 8.3 | 1.6 | 8.4 | 1.5 | ||||
| Men | 8.1 | 1.7 | 8.2 | 1.6 | 8.4 | 1.5 | ||||
| Women | 8.1 | 1.8 | 8.3 | 1.7 | 8.5 | 1.5 | ||||
| 6 mo | ||||||||||
| All participants | 8.2 | 1.6 | 8.3 | 1.6 | 8.4 | 1.6 | ||||
| Men | 8.1 | 1.7 | 8.3 | 1.5 | 8.4 | 1.6 | ||||
| Women | 8.3 | 1.5 | 8.3 | 1.6 | 8.3 | 1.7 | ||||
| 9 mo | ||||||||||
| All participants | 8.1 | 1.8 | 8.4 | 1.6 | 8.4 | 1.7 | ||||
| Men | 8.2 | 1.7 | 8.6 | 1.4 | 8.5 | 1.6 | ||||
| Women | 8.2 | 1.7 | 8.5 | 1.5 | 8.4 | 1.7 | ||||